Tatebe Masahiro, Urata Shiro, Tanaka Kenji, Kurahashi Toshikazu, Takeda Shinsuke, Hirata Hitoshi
Department of Hand Surgery, Nagoya University School of Medicine, Showaku, Nagoya, Japan.
Hand and Microsurgery Center, Anjo Kosei Hospital, Anjo, Japan.
J Hand Microsurg. 2017 Aug;9(2):92-94. doi: 10.1055/s-0037-1605353. Epub 2017 Jul 31.
Revascularization of damaged limbs/digits is technically feasible, but indications for surgical replantation remain controversial. The authors analyzed the survival rate of upper limb amputations and the associated factors in different age groups. They grouped 371 limb/digit amputees (average age, 44 years; range, 2-85 years) treated in their hospital during the past 10 years into three groups based on age (young, ≤ 15 years, = 12; adult, 16-64 years, = 302; elderly, ≥ 65 years, = 57) and analyzed their injury type (extent of injury and stump status), operation method, presence of medical complications (Charlson comorbidity index), and survival rate. There were 168 replantations, and the overall replantation survival rate was 93%. The Charlson comorbidity index of the replantation patients was 0 in 124 cases; 1 in 32; 2 in 9; and 3 in 3, but it did not show any significant difference in survival rate after replantation. Eight elderly patients (14%) did not opt for replantation. Younger patients tended to undergo replantation, but they had lower success rates due to their severe injury status. The results of this study show that the survival rate of replantation in elderly patients is equal to that in adults. Stump evaluation is important for survival, but the presence of medical complications is not associated with the overall survival rate.
受损肢体/手指的血管重建在技术上是可行的,但手术再植的指征仍存在争议。作者分析了上肢截肢的存活率及不同年龄组的相关因素。他们将过去10年在其医院接受治疗的371例肢体/手指截肢患者(平均年龄44岁;范围2 - 85岁)根据年龄分为三组(儿童,≤15岁,n = 12;成年人,16 - 64岁,n = 302;老年人,≥65岁,n = 57),并分析了他们的损伤类型(损伤程度和残端状况)、手术方法、医疗并发症情况(查尔森合并症指数)及存活率。共进行了168例再植手术,总体再植存活率为93%。再植患者的查尔森合并症指数为0的有124例;为1的有32例;为2的有9例;为3的有3例,但再植术后存活率未显示出任何显著差异。8例老年患者(14%)未选择再植。年轻患者倾向于接受再植,但由于其损伤严重,成功率较低。本研究结果表明,老年患者的再植存活率与成年人相当。残端评估对存活率很重要,但医疗并发症的存在与总体存活率无关。